Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
Event Date |
Wed Aug 16 +08 - Thu Aug 17 +08 (over 1 year ago)
In your timezone (EST): Tue Aug 15 12:00pm - Wed Aug 16 12:00pm |
Location |
Hotel Fort Canning
11 Canning Walk, Singapore 178881 |
Region | APAC |
Life science companies are poised to expand significantly in Asia Pacific through 2025, driving demand for real estate to develop R&D hubs, medical facilities, and laboratories as well as related warehouses and offices, according to an industry survey by JLL released in May of last year. Recent survey by KPMG stated 60% of healthcare and life sciences (HCLS) investors have indicated their plan to increase their real estate mergers and acquisitions activity in 2023. CLA Holdings (a wholly owned subsidiary of Temasek) has recently made US$220 million in investment commitments with plans to develop purpose-built innovation districts with collaborative life sciences infrastructure and specialised facilities. During Q3 2022, demand for space reached 2.1 million sq. ft., while new lab space under construction or redevelopment was 866,013 sq. ft. Developers are rushing to build life science related infrastructure, as supply of lab space is being sorely lacked. This shortage of medical & life science facilities is only rocketing the rental and purchasing price of HCLS facilities to the sky.
Life science properties have continued to command high sale prices last year, with the average facility trading at US$645 per square foot, 150% higher than the overall average of US$258 per square foot for general office buildings. Buildings that are candidates for lab space conversions can command higher prices, too. The appetite and willingness to spend in HCLS real estate has drawn strong interest, including Chinese biomedical companies which are motivated to explore South-east Asia as a potential growth market. Dutch pension funds manager PGGM launched a US$720 million joint venture this year with Australian real estate group Lendlease to invest in innovation and life sciences properties across Australia, Japan, and Singapore.
Come join us at Summit by Trueventus as we bring you innovative solutions and emerging trends for development and maintenance of specialized HCLS facilities. Engage in discussions with industry leaders as they share their insight of industry with extensive networking opportunities.